Erschienen in:
11.01.2024 | CORRESPONDENCE
Native aortic valve regurgitation and transcatheter aortic valve replacement: a word of caution or still too early?
verfasst von:
Carlos A. Mestres
Erschienen in:
Indian Journal of Thoracic and Cardiovascular Surgery
|
Ausgabe 2/2024
Einloggen, um Zugang zu erhalten
Excerpt
Among some different meanings, a pantheon is “a small group of people or things that are considered to be the most important ones of their type” [
1]. Another meaning contemplated by the Cambridge Dictionary, too, is “all the gods in a particular belief system, considered as a group” [
1]. The situation is then that transcatheter aortic valve implantation (TAVI), which has revolutionized our views, feelings, diagnosis, and treatment of, initially and specifically, degenerative calcific aortic valve stenosis in the inoperable elderly patient [
2], has become the first-line option in the treatment of aortic valve disease. Over time, physicians have extended the reach of this therapy, already 20 years old [
3], to a diversity of patient cohorts considered at different types of risk and are now approaching a diversity of pathologies and anatomies such as pure native aortic valve regurgitation [
4,
5]. …
